Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: Evaluation of the immature platelet fraction

References

• Rinder HM, Munz UJ, Ault KA, Bonan JL, Smith BR. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993;117:606–610
   PubMed Web of Science ®Google Scholar
• Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637–646
   PubMed Web of Science ®Google Scholar
• Abe Y, Wada H, Sakakura M, Nishioka J, Tomatsu H, Hamaguchi Y, Oguni S, Shiku H, Nobori T. Usefulness of fully automated measurement of reticulated platelets using whole blood. Clin Appl Thromb Hemos 2005;11:263–270
   PubMed Web of Science ®Google Scholar
• Kickler TS, Oguni S, Borowitz MJ. A clinical evaluation of high fluorescent platelet fraction percentage in thrombocytopenia. Am J Clin Pathol 2006;125:282–287
   PubMed Web of Science ®Google Scholar
• Briggs C, Kunka S, Hart D, Oguni S, Machin SJ. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004;126:93–99
   PubMed Web of Science ®Google Scholar
• Abe Y, Wada H, Tomatsu H, Sakaguchi A, Nishioka J, Yabu Y, Onishi K, Nakatani K, Morishita Y, Oguni S, et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 2006;118:463–469
   PubMed Web of Science ®Google Scholar
• Takami A, Shibayama M, Orito M, Omote M, Okumura H, Yamashita T, Shimadoi S, Yoshida T, Nakao S, Asakura H. Immature platelet fraction for prediction of platelet engraftment after allogeneic stem cell transplantation. Bone Marrow Transplant 2007;39:501–507
   PubMed Web of Science ®Google Scholar
• Kurata Y, Hayashi S, Kiyoi T, Kosugi S, Kashiwagi H, Honda S, Tomiyama Y. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 2001;115:656–664
   PubMed Web of Science ®Google Scholar
• Briggs C, Hart D, Kunka S, Oguni S, Machin SJ. Immature platelet fraction measurement: A future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 2006;16:101–109
   PubMed Web of Science ®Google Scholar
• Zucker ML, Murphy CA, Rachel JM, Martinez GA, Abhyankar S, McGuirk JP, Reid KJ, Plapp FV. Immature platelet fraction as a predictor of platelet recovery following hematopoietic progenitor cell transplantation. Lab Hematol 2006;12:125–130
   PubMedGoogle Scholar
• Saigo K, Sakota Y, Masuda Y. Clinical utility of new parameters provided by XE-2100 RET channel. Sysmex J Inter 2007;2:81–94
   Google Scholar
• Aster RH. Pooling of platelets in the spleen: Role in the pathogenesis of ‘hypersplenic’ thrombocytopenia. J Clin Invest 1966;45:645–657
   PubMed Web of Science ®Google Scholar
• McAllister E, Goode S, Cordista AG, Rosemurgy A. Partial portal decompression alleviates thrombocytopenia of portal hypertension. Am Surg 1995;61:129–131
   PubMed Web of Science ®Google Scholar
• Alvarez OA, Lopera GA, Patel V, Encarnacion CE, Palmaz JC, Lee M. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol 1996;91:134–137
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Freedman AM, Purdum PP, Shiffman ML, Luketic VA. The hematologic consequences of transjugular intrahepatic portosystemic shunts. Hepatology 1996;23:32–39
   PubMed Web of Science ®Google Scholar
• Gschwantler M, Vavrik J, Gebauer A, Kriwanek S, Schrutka-Kölbl C, Fleischer J, Madani B, Brownstone E, Tscholakoff D, Weiss W. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt-a prospective, controlled study. J Hepatol 1999;30:254–259
   PubMed Web of Science ®Google Scholar
• Jabbour N, Zajko A, Orons P, Irish W, Fung JJ, Selby RR. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci 1998;43:2459–2465
   PubMed Web of Science ®Google Scholar
• Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, Todo S, Gordon RD, Iwatsuki S. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989;210:180–183
   PubMed Web of Science ®Google Scholar
• Kaushansky K. Thrombopoietin: The primary regulator of megakaryocyte and platelet production. Thromb Haemost 1995;74:521–525
   PubMed Web of Science ®Google Scholar
• Eaton DL, de Sauvage EJ. Thrombopoietin. The primary regulator of megakaryocytopoiesis and thrombopoieis. Exp Hematol 1995;25:1–7
   Web of Science ®Google Scholar
• Jelkmann W. The role of liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol 2001;13:791–801
   PubMed Web of Science ®Google Scholar
• Radosavljevic M. Thrombocytopenia in liver disease. Can J Gastroenterol 2000;14:60–66
   Google Scholar
• Doi T, Homma H, Mezawa S, Kato J, Kogawa K, Sakamaki S, Niitsu Y. Mechanisms for increment of platelet associated IgG and platelet surface IgG and their implications in immune thrombocytopenia associated with chronic viral liver disease. Hepatol Res 2002;24:23–33
   PubMed Web of Science ®Google Scholar
• Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Osada J, Wysocka J. Activation of bloodplatelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepato-Gastroenterology 2001;48:818–822
   PubMed Web of Science ®Google Scholar
• Lebensztejn DM, Kaczmarski M. Lamivudine-associated thrombocytopenia. Am J Gastroenterol 2002;97:2687–2688
   PubMed Web of Science ®Google Scholar
• Ballard HS. Hematological complications of alcoholism. Alcohol Clin Exp Res 1989;13:706–720
   PubMed Web of Science ®Google Scholar
• Drews RE. Critical issues in hematology: Anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 2003;24:607–622
   PubMed Web of Science ®Google Scholar
• Anonymous. Management scheme of diagnostic and therapy criteria of viral hepatitis. Chinese J Hepatol 2000;6:324–329
   Google Scholar
• Huo TI, Wu JC, Lin HC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Evaluation of the increase in model for end-stage liver disease (DMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: Risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score. J Hepatol 2005;42:826–832
   PubMed Web of Science ®Google Scholar
• Dardenne AN. 1993. The spleen. In: Cosgrove DO, Meire HB, Dewbury KCD, editors. Clinical Ultrasound. Edinburgh: Churchill Livingstone. pp 353–365
   Google Scholar
• Panasiuk A, Prokopowicz D. Platelet autoantibodies in liver cirrhosis and thrombocytopenia. Rocz Akad Med Bialymst 2000;45:54–62
   PubMedGoogle Scholar
• Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol 2003;18:638–644
   PubMed Web of Science ®Google Scholar
• Kajihara M, Kato S, Okazaki Y, Kawakami Y, Ishii H, Ikeda Y, Kuwana M. A role of autoantibody-mediated platelet destruction in thrombocytopenia in patients with cirrhosis. Hepatology 2003;37:1267–1276
   PubMed Web of Science ®Google Scholar
• Kajiwara E, Akagi K, Azuma K, Onoyama K, Fujishima M. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease. Am J Gastroenterol 1995;90:962–966
   PubMed Web of Science ®Google Scholar
• Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 1995;22:1682–1688
   PubMed Web of Science ®Google Scholar
• Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol 1995;50:173–178
   PubMed Web of Science ®Google Scholar
• Aoki Y, Hirai K, Tanikawa K. Mechanism of thrombocytopenia in liver cirrhosis: Kinetics of indium-111 tropolone labelled platelets. Eur J Nucl Med 1993;20:123–129
   PubMedGoogle Scholar
• Kaushansky K. Thrombopoietin: Basic biology, clinical promise. Int J Hematol 1995;62:7–15
   PubMed Web of Science ®Google Scholar
• Koike Y, Yoneyama A, Shirai J, Ishida T, Shoda E, Miyazaki K, Sunaga S, Horie R, Aoki K, Koike K, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 1998;79:1106–1110
   PubMed Web of Science ®Google Scholar
• Peck-Radosavljevic M, Wichlas M, Zacherl J, Stiegler G, Stohlawetz P, Fuchsjäger M, Kreil A, Metz-Schimmerl S, Panzer S, Steininger R, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 2000;95:795–801
   PubMed Web of Science ®Google Scholar
• Wolber EM, Ganschow R, Burdelski M, Jelkmann W. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology 1999;29:1739–1742
   PubMed Web of Science ®Google Scholar
• Aref S, Mabed M, Selim T, Goda T, Khafagy N. Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology 2004;9:351–356
   PubMedGoogle Scholar
• Goulis J, Chau TN, Jordan S, Mehta AB, Watkinson A, Rolles K, Burroughs AK. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation. Gut 1999;44:754–758
   PubMed Web of Science ®Google Scholar
• Peck-Radosavljevic M, Zacherl J, Wichlas M, Sims P, Meng YG, Panzer S, Lipinski E, Steininger R, Mühlbacher F, Pidlich J, et al. Thrombopoietic cytokines and reversal of thrombocytopenia after liver transplantation. Eur J Gastroenterol Hepatol 1999;11:151–156
   PubMed Web of Science ®Google Scholar
• Zucker ML, Hagedorn CH, Murphy CA, Stanley S, Reid KJ, Skikne BS. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction. Int J Lab Hematol 2012;34:525–532
   PubMed Web of Science ®Google Scholar